Apyx Medical Corporation (APYX)
After hours:
| Previous Close | 1.4000 |
| Open | 1.3807 |
| Bid | 1.3900 x 100 |
| Ask | 1.4700 x 100 |
| Day's Range | 1.3807 - 1.4650 |
| 52 Week Range | 1.2100 - 7.9700 |
| Volume | |
| Avg. Volume | 155,062 |
| Market Cap | 49.194M |
| Beta (5Y Monthly) | 1.12 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5400 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.63 |
- Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
CLEARWATER, Fla., April 25, 2024--Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
- Business Wire
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
CLEARWATER, Fla., April 11, 2024--Apyx® Medical Corporation (NASDAQ:APYX) (the "Apyx Medical"; "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, is pleased to announce the Renuvion Users’ Summit is taking place in Las Vegas from April 12-13, 2024.
Simply Wall St.Downgrade: Here's How Analysts See Apyx Medical Corporation (NASDAQ:APYX) Performing In The Near Term
One thing we could say about the analysts on Apyx Medical Corporation ( NASDAQ:APYX ) - they aren't optimistic, having...
